{"id":5510,"date":"2011-03-02T14:39:33","date_gmt":"2011-03-02T13:39:33","guid":{"rendered":"http:\/\/www.ethicalquote.com\/?p=5510"},"modified":"2011-03-07T14:45:22","modified_gmt":"2011-03-07T13:45:22","slug":"medtronic","status":"publish","type":"post","link":"https:\/\/www.covalence.ch\/index.php\/2011\/03\/02\/medtronic\/","title":{"rendered":"Medtronic Answers United Nations\u2019 Call for \u201cInternational Commitment\u201d to Non-Communicable Diseases"},"content":{"rendered":"<p><a href=\"http:\/\/wwwp.medtronic.com\/Newsroom\/NewsReleaseDetails.do?itemId=1299098193173&amp;lang=en_US\"><img loading=\"lazy\" decoding=\"async\" class=\"alignright size-full wp-image-5513\" title=\"110307_ncd\" src=\"http:\/\/www.ethicalquote.com\/newTemplate\/wp-content\/uploads\/2011\/03\/110307_ncd.jpg\" alt=\"\" width=\"200\" height=\"130\" \/><\/a>In its continued commitment to reduce the global burden of  non-communicable diseases (NCDs), Medtronic, Inc. today announced it  will make nearly $4 million in Medtronic Foundation grants in 2011 to  international organizations specifically to address diseases such as  diabetes and heart disease in developing countries.\u00c2\u00a0 With  non-communicable diseases accounting for 60 percent of all deaths  worldwide, U.N. Secretary-General Ban Ki-moon earlier this year called  upon the world&#8217;s businesses to help address NCDs, which are expected to  increase by 50 percent in developing countries by 2030. \u00c2\u00a0\u00c2\u00a0NCDs account  for roughly 75 percent of healthcare costs in both advanced and  developing economies, according to the World Economic Forum. \u201cThe  cost in human life and health is just one dimension of the global  epidemic of non-communicable disease,\u201d said Bill Hawkins, Medtronic\u2019s  chairman and chief executive officer.\u00c2\u00a0 \u201cInsufficient management of  chronic illness can have a devastating impact on economic growth and  productivity, especially in the world\u2019s most underserved communities  where access to prevention, diagnosis and treatment options are often  severely limited.\u201d Image: pih.org. <a href=\"http:\/\/wwwp.medtronic.com\/Newsroom\/NewsReleaseDetails.do?itemId=1299098193173&amp;lang=en_US\" target=\"_blank\">More&#8230;<\/a><\/p>\n<p>News selected by Covalence | Country: Global | Company: Medtronic | Source: <a href=\"http:\/\/wwwp.medtronic.com\/Newsroom\/NewsReleaseDetails.do?itemId=1299098193173&amp;lang=en_US\" target=\"_blank\">Medtronic<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>In its continued commitment to reduce the global burden of non-communicable diseases (NCDs), Medtronic, Inc. today announced it will make nearly $4 million in Medtronic Foundation grants in 2011 to international organizations specifically to address diseases such as diabetes and heart disease in developing countries.\u00c2\u00a0 With non-communicable diseases accounting for 60 percent of all deaths&hellip;<\/p>\n","protected":false},"author":665,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_exactmetrics_skip_tracking":false,"_exactmetrics_sitenote_active":false,"_exactmetrics_sitenote_note":"","_exactmetrics_sitenote_category":0,"wds_primary_category":0,"wds_primary_post_series":0,"footnotes":""},"categories":[1],"tags":[519],"post_series":[],"class_list":["post-5510","post","type-post","status-publish","format-standard","hentry","category-news","tag-medtronic","entry","no-media"],"_links":{"self":[{"href":"https:\/\/www.covalence.ch\/index.php\/wp-json\/wp\/v2\/posts\/5510","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.covalence.ch\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.covalence.ch\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.covalence.ch\/index.php\/wp-json\/wp\/v2\/users\/665"}],"replies":[{"embeddable":true,"href":"https:\/\/www.covalence.ch\/index.php\/wp-json\/wp\/v2\/comments?post=5510"}],"version-history":[{"count":0,"href":"https:\/\/www.covalence.ch\/index.php\/wp-json\/wp\/v2\/posts\/5510\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.covalence.ch\/index.php\/wp-json\/wp\/v2\/media?parent=5510"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.covalence.ch\/index.php\/wp-json\/wp\/v2\/categories?post=5510"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.covalence.ch\/index.php\/wp-json\/wp\/v2\/tags?post=5510"},{"taxonomy":"post_series","embeddable":true,"href":"https:\/\/www.covalence.ch\/index.php\/wp-json\/wp\/v2\/post_series?post=5510"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}